Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice

Clinical Cancer Research

Volumn 15, Issue 17, 2009, Pages 5435-5444

  Tsai, Chin Hsien ^a,c   Lin, Feng Min ^a   Yang, Yu Chih ^a   Lee, Ming Ting ^b,c   Cha, Tai Lung ^d   Wu, Guan James ^a   Hsieh, Shih Chuan ^a   Hsiao, Pei Wen ^a  

^a AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; APIGENIN; LUTEOLIN; PLANT EXTRACT; UNCLASSIFIED DRUG; WEDELIA CHINENSIS EXTRACT; WEDELOLACTONE;

ALTERNATIVE MEDICINE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EXPOSURE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; ORTHOTICS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TREATMENT DURATION; TUMOR CELL; TUMOR VOLUME; TUMOR XENOGRAFT; WEDELIA;

ADMINISTRATION, ORAL; ANDROGEN ANTAGONISTS; ANIMALS; APIGENIN; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COUMARINS; DRUGS, CHINESE HERBAL; HUMANS; LUTEOLIN; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PHYTOTHERAPY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; WEDELIA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 69949089790     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0298     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Crawford ED. Challenges in the management of prostate cancer. Br J Urol 1992;70 Suppl 1:33-38
3. Pienta KJ, Smith DC. Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J Clin 2005;55:300-18, quiz 323-5
4. Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003;21:383-391
5. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J. An androgen response elementin a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 1997;11:148-161
6. Attardi BJ, Burgenson J, Hild SA, Reel JR. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells. Mol Cell Endocrinol 2004;222:121-132
7. Sramkoski RM, Pretlow TG II, Giaconia JM, et al. A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim 1999;35:403-409
8. Lin FM, Chen LR, Lin EH, et al. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. Carcinogenesis 2007;28:2521-2529
9. Lin FM, Tsai CH, Yang YC, et al. A novel diterpene suppresses CWR22Rv1 tumor growth in vivo through antiproliferation and proapoptosis. Cancer Res 2008;68:6634-6642
10. Tu WC, Wang SY, Chien SC, et al. Diterpenes from Cryptomeria japonica inhibitandrogen receptor transcriptional activity in prostate cancer cells. Planta Med 2007;73:1407-1409
11. 2-M arresta nd apoptosis of renal cancer cells. Clin Cancer Res 2009;15:840-850
12. Wester K, Ranefall P, Bengtsson E, Busch C, Malmstrom PU. Automatic quantification of microvessel density in urinary bladder carcinoma. Br J Cancer 1999;81:1363-1370
13. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58:621-681
14. 2-M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998;18:629-643
15. Shukla S, Gupta S. Molecular targets for apigenin-induced cell cycle arrestand apoptosis in prostate cancer cell xenograft. Mol Cancer Ther 2006;5:843-852
16. Shukla S, Mishra A, Fu P, MacLennan GT, Resnick MI, Gupta S. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograftin athymic nude mice. FASEB J 2005;19:2042-2044
17. Eder M, Mehnert W. The importance of concomitant compounds in plant extracts. Die Pharmazie 1998;53:285-293
18. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 2002;20:1069-1079
19. Huie CW. A review of modern sample-preparation techniques for the extraction and analysis of medicinal plants. Anal Bioanal Chem 2002;373:23-30.
20. Khan IA. Issues related to botanicals. Life Sci 2006;78:2033-2038
21. Pettaway CA, Pathak S, Greene G, et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996;2:1627-1636
22. Rembrink K, Romijn JC, van der Kwast TH, Rubben H, Schroder FH. Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer. Prostate 1997;31:168-174
23. Klein EA, Thompson IM. Update on chemoprevention of prostate cancer. Curr Opin Urol 2004;14:143-149
24. Neill MG, Fleshner NE. An update on chemoprevention strategies in prostate cancer for 2006. Curr Opin Urol 2006;16:132-137
25. Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH. Chemoprevention strategies for prostate cancer. Eur J Cancer Prev 2002;11 Suppl 2:S18-27.
26. Aziz MH, Dreckschmidt NE, Verma AK. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res 2008;68:9024-9032
27. Cha TL, Qiu L, Chen CT, Wen Y, Hung MC. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res 2005;65:2287-2295
28. 1 cell cycle arrestand apoptosis in prostate cancer cells. Oncogene 2001;20:2927-2936
29. Guo J, Jiang C, Wang Z, et al. A novel class of pyranocoumarin anti-androgen receptor signaling compounds. Mol Cancer Ther 2007;6:907-917
30. Hsu JC, Zhang J, Dev A, Wing A, Bjeldanes LF, Firestone GL. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells. Carcinogenesis 2005;26:1896-1904
31. Jiang C, Lee HJ, Li GX, et al. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Cancer Res 2006;66:453-463
32. Yang H, Chen D, Cui QC, Yuan X, Dou QP. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 2006;66:4758-4765
33. 1 arrestand apoptosis in human prostate carcinoma cells. Cancer Res 2005;65:1035-1044
34. Zi X, Zhang J, Agarwal R, Pollak M. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independentpro state cancer cells. Cancer Res 2000;60:5617-5620
35. Fang J, Zhou Q, Shi XL, Jiang BH. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis 2007;28:713-723
36. Shukla S, Gupta S. Molecular mechanisms for apigenin-induced cell-cycle arrestand apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol Carcinog 2004;39:114-126
37. Bagli E, Stefaniotou M, Morbidelli L, et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res 2004;64:7936-7946
38. Fang J, Zhou Q, Liu LZ, et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis 2007;28:858-864
39. Shukla S, MacLennan GT, Flask CA, et al. Blockade of β-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res 2007;67:6925-6935
40. Wan L, Guo C, Yu Q, et al. Quantitative determination of apigenin and its metabolism in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry. J Chromatogr 2007;855:286-289
41. Chen T, Li LP, Lu XY, Jiang HD, Zeng S. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem 2007;55:273-277